On average, Reelin levels rise two to threefold under chronic or low-grade inflammatory conditions [53,74], and up to fivefold during acute or severe inflammation, as observed in COVID-19 patients experiencing a cytokine storm [74]. The gene discussed is RELN; the disease is COVID-19.